Optimal P2Y12 inhibition in older adults with acute coronary syndromes: a network meta-analysis of randomized controlled trials

被引：0
|
作者：
Montalto, Claudio [1 ]
Morici, Nuccia [2 ]
Munafo, Andrea Raffaele [1 ]
Mangieri, Antonio [3 ]
Mandurino-Mirizzi, Alessandro [1 ]
D'Ascenzo, Fabrizio [4 ]
Oreglia, Jacopo [2 ]
Latib, Azeem [5 ]
Porto, Italo [6 ]
Colombo, Antonio [3 ]
Savonitto, Stefano [7 ]
De Servi, Stefano [8 ]
Crimi, Gabriele [6 ]
机构：
[1] IRCCS Fdn Policlin San Matteo, Pavia, Italy
[2] Asst Grande Osped Metropolitano Niguarda, Milan, Italy
[3] Maria Cecilia Hosp, Cotignola, Ravenna, Italy
[4] Univ Turin, Turin, Italy
[5] Montefiore Med Ctr, New York, NY USA
[6] Univ Genoa, Aou San Martino IST, Genoa, Italy
[7] Manzoni Hosp, Lecce, Italy
[8] Univ Pavia, Pavia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0N期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
249
引用
收藏
页码：N109 / N109
页数：1
相关论文
共 50 条
  • [31] P2Y12 inhibitor monotherapy and dual antiplatelet therapy after percutaneous coronary intervention: An updated meta-analysis of randomized trials
    Jin, Yao
    Huang, Hui
    Shu, Xinyi
    Chen, Shuai
    Lu, Lin
    Gao, Xiang
    Wu, Zhijun
    THROMBOSIS RESEARCH, 2021, 198 : 115 - 121
  • [32] Introduction -: Emerging issues and new pharmacologic options for P2Y12 inhibition in acute coronary syndromes
    Wallentin, Lars
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D2 - D2
  • [33] Effect of oral P2Y12 receptor inhibitors in acute coronary syndromes treated with and without percutaneous coronary intervention: a meta-analysis of nonsmokers.
    Bailey, William L.
    Salek, Firoozeh S.
    Tantry, Udaya S.
    Bliden, Kevin P.
    Gurbel, Paul A.
    PHARMACOTHERAPY, 2014, 34 (10): : E184 - E185
  • [34] Safety and Effectiveness of P2Y12 Inhibitors in Critically Ill Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials
    Singh, Sahib
    Tantry, Udaya
    Bliden, Kevin
    Gurbel, Paul
    CIRCULATION, 2023, 148
  • [35] Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors
    Bangalore, Sripal
    Toklu, Bora
    Kotwal, Anupam
    Volodarskiy, Alexander
    Sharma, Sahil
    Kirtane, Ajay J.
    Feit, Frederick
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [36] Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population
    Hou, Mingxi
    Hyun, Karice
    Chew, Derek P.
    Kritharides, Leonard
    Amos, David
    Brieger, David
    HEART LUNG AND CIRCULATION, 2022, 31 (08): : 1085 - 1092
  • [37] Clash of Oral P2Y12 Receptor Inhibitors in Acute Coronary Syndromes
    Chatzizisis, Yiannis S.
    Stefanadis, Christodoulos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (04) : 382 - 385
  • [38] Trajectories of P2Y12 inhibitor adherence in patients with acute coronary syndromes
    Moon, Jungyeon
    Ozaki, Aya F.
    Chong, Alice
    Sud, Maneesh
    Fang, Jiming
    Austin, Peter C.
    Ko, Dennis T.
    Jackevicius, Cynthia A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [39] Association of 2B3A inhibition with new antiplatelet regimens in the setting of acute coronary syndromes: a meta-analysis of randomized controlled trials
    Beygui, F.
    Agueznai, M.
    Roule, V.
    Sabatier, R.
    Lognone, T.
    Bellemain-Appaix, A.
    Collet, J. P.
    Montalescot, G.
    Milliez, P.
    EUROPEAN HEART JOURNAL, 2013, 34 : 886 - 886
  • [40] Early vs. Delayed Initiation of Treatment With P2Y12 Inhibitors in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
    Vicent, Lourdes
    Diaz-Arocutipa, Carlos
    Tarantini, Giuseppe
    Mojoli, Marco
    Hernandez, Adrian V.
    Bueno, Hector
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345